Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alto Neuroscience, Inc. (ANRO)
NYSE:ANRO
Alto Neuroscience, Inc. (ANRO) Stock Price & Analysis
32 Followers
ANRO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$12.78 - $24.00
Previous Close$14.22
Volume114.89K
Average Volume (3M)214.52K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$82.55M
Total Debt (Recent Filing)$9.86M
Price to Earnings (P/E)N/A
Beta1.00
Next Earnings
Mar 21, 2024EPS Estimate
-$0.84Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding26,883,988
10 Day Avg. Volume73,447
30 Day Avg. Volume214,522
Standard Deviation0.00966
R-Squared1.00
Alpha0.00259
Financial Highlights & Ratios
Price to Book (P/B)-5.33
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-8.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$32.33Price Target Upside127.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Alto Neuroscience, Inc. News
PremiumCompany Announcements
Alto Neuroscience Welcomes Dr. Radhakrishnan to Board
PremiumStock Analysis & Ideas
Analysts Bet Big on These Beaten-Down IPO StocksOwnership Overview
24.97% Insiders
4.09% Mutual Funds
3.87% Other Institutional Investors
67.07% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ANRO FAQ
What was Alto Neuroscience, Inc.’s price range in the past 12 months?
Alto Neuroscience, Inc. lowest stock price was $12.78 and its highest was $24.00 in the past 12 months.
What is Alto Neuroscience, Inc.’s market cap?
Currently, no data Available
When is Alto Neuroscience, Inc.’s upcoming earnings report date?
Alto Neuroscience, Inc.’s upcoming earnings report date is Mar 21, 2024 which is 46 days ago.
How were Alto Neuroscience, Inc.’s earnings last quarter?
Currently, no data Available
Is Alto Neuroscience, Inc. overvalued?
According to Wall Street analysts Alto Neuroscience, Inc.’s price is currently Undervalued.
Does Alto Neuroscience, Inc. pay dividends?
Alto Neuroscience, Inc. does not currently pay dividends.
What is Alto Neuroscience, Inc.’s EPS estimate?
Alto Neuroscience, Inc.’s EPS estimate is -$0.84.
How many shares outstanding does Alto Neuroscience, Inc. have?
Alto Neuroscience, Inc. has 26,883,987 shares outstanding.
What happened to Alto Neuroscience, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Alto Neuroscience, Inc.?
Currently, no hedge funds are holding shares in ANRO
---
Alto Neuroscience, Inc. Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$32.33 (127.36% Upside)
$32.33 (127.36% Upside)
Insider Transactions
Bought Shares
Worth $10.0M over
the Last 3 Months
the Last 3 Months
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
70.35%
Trailing 12-Months
Company Description
Alto Neuroscience, Inc.
Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients¿ brain activity and behavior to better identify which patients are more likely to respond to our novel product candidates.
---
ANRO Stock 12 Months Forecast
Average Price Target
$32.33
▲(127.36% Upside)
Technical Analysis
---